EQS-News: Cherry SE: TI Messenger by CHERRY Digital Health Approved for Communication with Patients and Health Insurers
|
EQS-News: Cherry SE
/ Key word(s): Regulatory Approval
Munich, 10. December 2025 – Cherry SE: CHERRY Digital Health is now offering healthcare providers a secure digital communication channel for interacting with patients and health insurers. The company has received gematik approval for its CHERRY TIM.Pro messenger.
Doctors, physiotherapists, pharmacists and other healthcare providers can now communicate with patients and health insurers in real time, send medical findings, and answer questions regarding medications – all in compliance with GDPR and across sectors via a single, user-friendly platform. TIM.Pro can be used both on computers and smartphones, enabling flexible and device-independent communication. Currently, healthcare providers still rely heavily on telephone and analog communication methods. Digital communication with patients often takes place via insecure services such as email or even WhatsApp. TIM.Pro is a modern digital alternative that – unlike conventional messaging services – meets all GDPR requirements and is approved by gematik. This ensures the highest security standards for sensitive medical data. TIM.Pro enables more efficient medical care. Patients can submit questions with ease, for instance when their medication instructions are unclear. At the same time, the platform helps physicians structure their day more effectively: inquiries can be answered when the schedule allows, not only when the phone happens to ring. Consultation appointments can also be arranged without time-consuming phone calls, for example to discuss lab results. Dr. Philip Groth, Managing Director of CHERRY Digital Health, said: “The provider approval by gematik confirms the quality and security of our TI Messenger offering. Together with our partners, we can now provide all healthcare providers with a product that significantly simplifies communication with patients and health insurers. We have taken another major step toward our goal of making communication in the healthcare sector more efficient, secure and user-friendly.“ Key advantages of the CHERRY TI Messenger:
CHERRY TIM.Pro is based on the innovative technology of Awesome Technologies and has been specifically developed for the needs of the German healthcare sector. It complements CHERRY Digital Health’s portfolio. With this provider approval, CHERRY Digital Health reinforces its position as a leading provider of health technologies and a reliable partner for all stakeholders in the healthcare system. The controlled rollout of the CHERRY TIM.Pro has successfully begun. During this phase, the technology and associated processes will be continuously tested and optimized to ensure smooth nationwide deployment. Once the controlled rollout is complete, the CHERRY TIM.Pro is expected to be available across Germany starting in the first quarter of 2026. Further information about CHERRY TIM.Pro can be found here.
About Cherry Cherry SE [ISIN: DE000A3CRRN9] is a global manufacturer of computer input devices such as keyboards, mice, microphones, and headsets for applications in office, gaming, and industry for hybrid work, as well as hardware and software solutions in digital healthcare. Since its founding in 1953, CHERRY has been synonymous with innovative and durable high-quality products, developed in-house, specifically to meet customer needs. CHERRY’s operational headquarters is in Germany (Auerbach in der Oberpfalz) and it employs staff in development, services, logistics, and production sites in Germany (Auerbach), China (Zhuhai), and Austria (Vienna), as well as in multiple sales offices in Germany (Munich, Auerbach), France (Paris), Sweden (Landskrona), the USA (Kenosha), China (Shanghai) and Taiwan (Taipei). For more information, visit:https://ir.cherry.de/en/
Contact Cherry SE
10.12.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Cherry SE |
| Rosental 7, c/o Mindspace | |
| 80331 Munich | |
| Germany | |
| ISIN: | DE000A3CRRN9 |
| WKN: | A3CRRN |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2243186 |
| End of News | EQS News Service |
|
|
2243186 10.12.2025 CET/CEST
Zur besseren Einschätzung der fundamentalen Entwicklung der jeweiligen Unternehmen bietet boersengefluester.de (BGFL) eine Übersicht mit den wesentlichen Kennzahlen zu Umsatz, Ergebnis, Cashflow und Dividende. Sämtliche Angaben werden manuell in unserer Datenbank erfasst – Quelle sind die jeweiligen Geschäftsberichte. Sofern es sich um Schätzungen für künftige Zahlen handelt, stammen sie durchweg von BGFL.
| Die wichtigsten Finanzdaten auf einen Blick | ||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | ||
| Umsatzerlöse1 | 114,72 | 130,20 | 168,53 | 132,51 | 126,46 | 110,45 | 106,00 | |
| EBITDA1,2 | 27,75 | 35,27 | 42,57 | 12,22 | -10,26 | -11,60 | 1,00 | |
| EBITDA-Marge3 | 24,19 | 27,09 | 25,26 | 9,22 | -8,11 | -10,50 | 0,94 | |
| EBIT1,4 | 18,37 | 24,98 | 27,62 | -36,49 | -131,12 | -44,14 | -8,00 | |
| EBIT-Marge5 | 16,01 | 19,19 | 16,39 | -27,54 | -103,69 | -39,96 | -7,55 | |
| Jahresüberschuss1 | 12,52 | 17,54 | 9,29 | -35,73 | -126,88 | -45,45 | -9,00 | |
| Netto-Marge6 | 10,91 | 13,47 | 5,51 | -26,96 | -100,33 | -41,15 | -8,49 | |
| Cashflow1,7 | 21,35 | 22,78 | 7,82 | 5,77 | -27,80 | -45,45 | -7,00 | |
| Ergebnis je Aktie8 | 0,52 | 0,72 | 0,38 | -1,49 | -5,45 | -1,96 | -0,37 | |
| Dividende8 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: RSM Ebner Stolz
Alle relevanten Bewertungskennzahlen, Termine und sonstige Investor-Informationen zu Ihrer Aktie kompakt zusammengefasst. Gut zu wissen: Sämtliche Daten stammen von boersengefluester.de werden täglich aktualisiert. Damit sind Sie immer auf dem neuen Stand. Kurze Erkärungen zu den Kennzahlen bekommen Sie, wenn Sie mit dem Cursor bzw. der Maus auf das jeweilige Feld gehen.
| INVESTOR-INFORMATIONEN | ||||||
| ©boersengefluester.de | ||||||
| Cherry | ||||||
| WKN | ISIN | Rechtsform | Börsenwert | IPO | Einschätzung | Plus Code |
| A3CRRN | DE000A3CRRN9 | SE | 14,53 Mio € | 29.06.2021 | Beobachten | 8FWH4HPG+52 |
| KGV 2026e | KGV 10Y-Ø | BGFL-Ratio | Shiller-KGV | KBV | KCV | KUV |
| -7,48 | 0,00 | 0,00 | -0,84 | 0,19 | 5,11 | 0,13 |
|
Dividende '2023 in € |
Dividende '2024 in € |
Dividende '2025e in € |
Div.-Rendite '2025e in % |
| 0,00 | 0,00 | 0,00 | 0,00% |
| Hauptversammlung | Q1-Zahlen | Q2-Zahlen | Q3-Zahlen | Bilanz-PK |
| 22.07.2025 | 14.05.2025 | 26.09.2025 | 13.11.2025 | 30.05.2025 |
| Abstand 60-Tage-Linie | Abstand 200-Tage-Linie | Performance YtD | Kursveränderung 52 Wochen | IPO |
| -2,45% | -22,94% | -47,36% | -12,70% | -98,13% |
Auf dem 2013 von Gereon Kruse gegründeten Finanzportal boersengefluester.de dreht sich alles um deutsche Aktien – mit klarem Schwerpunkt auf Nebenwerte. Neben klassischen redaktionellen Beiträgen sticht die Seite insbesondere durch eine Vielzahl an selbst entwickelten Analysetools hervor. Basis sämtlicher Tools ist eine komplett selbst gepflegte Datenbank für mehr als 650 Aktien. Damit erstellt boersengefluester.de Deutschlands größte Gewinn- und Dividendenprognose.
Kontakt
